EODData

MEMBERSHIP REGISTER LOG IN

FRA, AMG: Amgen Inc.

17 Feb 2026
LAST:

316.2

CHANGE:
 6.00		OPEN:
307.8		HIGH:
316.2		ASK:
0.0		VOLUME:
160
CHG(%):
1.93		PREV:
310.2		LOW:
307.8		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Feb 26307.8316.2307.8316.2160
16 Feb 26309.8310.2309.8310.225
13 Feb 26305.2311.7305.2309.0410
11 Feb 26305.7309.9305.7309.9100
10 Feb 26315.1317.6311.4311.412
09 Feb 26323.8327.7314.2314.2262
06 Feb 26311.0311.8310.0311.815
05 Feb 26308.9318.1306.3312.8230
04 Feb 26286.0310.1286.0310.1894
03 Feb 26291.7291.7291.7291.75

PROFILE

Name:Amgen Inc.
About:Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Sector:Healthcare
Address:One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
Website:https://www.amgen.com
ISIN:US0311621009
LEI:62QBXGPJ34PQ72Z12S66

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:18.59 
Forward P/E:10.32 
PEG Ratio:0.27 
Price to Sales:4.18 
Price to Book:2.63 
Profit Margin:0.19 
Operating Margin:0.34 
Return on Assets:0.08 
Return on Equity:0.82 
EPS Ratio:16.69 
DivYield:0.04 
Div/Share:9.26 
Revenue:30.523B 
EBITDA:14.022B 
Shares:28.13M 
Market Cap:8.894B 

TECHNICAL INDICATORS

MA5:311.331.6%
MA10:309.722.1%
MA20:299.445.6%
MA50:287.779.9%
MA100:276.3514.4%
MA200:262.2120.6%
STO9:38.50
STO14:72.94
RSI14:72.47 
MTM14:28.05
ROC14:0.10 
ATR:7.16 
Week High:317.600.4%
Week Low:305.203.6%
Month High:327.703.6%
Month Low:278.7520.6%
Year High:327.703.6%
Year Low:230.0037.5%
Volatility:3.28 

RECENT DIVIDENDS

Date Amount
13 Feb 2026$2.12
21 Nov 2025$2.07
22 Aug 2025$2.04
16 May 2025$2.04
14 Feb 2025$2.04
18 Nov 2024$1.93
16 Aug 2024$1.93
16 May 2024$1.93
15 Feb 2024$1.93
16 Nov 2023$1.83